STOCK TITAN

Cresco Labs Opens Second Sunnyside in Miami, Florida

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Cresco Labs (OTCQX:CRLBF) continues its expansion in Florida with the opening of a new Sunnyside dispensary at 8717 SW 24th St., Miami, enhancing its retail presence to 29 locations statewide and 64 nationwide. The new facility aims to serve the growing patient base in Miami-Dade, the eighth most populous county in the U.S. with nearly 2.7 million residents. The store offers a broad range of cannabis products from Cresco's branded portfolio, including Cresco, One Plant, and Good News. CEO Charlie Bachtell emphasizes the company's commitment to reaching more patients in populous regions. The store operates Monday to Saturday from 9 AM to 8 PM and Sunday from 9 AM to 6 PM, allowing for both in-store and online orders.

Positive
  • Expansion to a second store in Miami, increasing total Florida dispensaries to 29 and nationwide locations to 64.
  • Focus on serving a populous area (Miami-Dade) with a significant patient base.
  • Offering a wide variety of cannabis products from multiple trusted brands.
Negative
  • None.

 

CHICAGO--(BUSINESS WIRE)-- Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or “the Company), a vertically integrated multistate cannabis operator and the No. 1 U.S. wholesaler of branded products, today announced it has expanded in Miami, Florida, with the addition of a second store on the west side located at 8717 SW 24th St. The Company’s Florida retail footprint has grown to 29 total dispensaries. Nationwide, Cresco has 64 operating locations.

Cresco Labs opened a second Sunnyside in west Miami, Florida, at 8717 SW 24th St. (Photo: Business Wire)

Cresco Labs opened a second Sunnyside in west Miami, Florida, at 8717 SW 24th St. (Photo: Business Wire)

“We’re continuing our Florida expansion effort to bring our highly productive retail model and differentiated portfolio of branded products to more patients living in populous regions,” said Charlie Bachtell, Cresco Labs’ CEO & Co-Founder. “Miami-Dade is the eighth most populous U.S. county, with nearly 2.7 million residents, and we look forward to our new Westchester store joining our existing west Miami store to better serve the growing patient base in South Florida. We’re excited to add our newest Sunnyside store to our growing store network.”

Like Sunnyside’s other Florida stores, this new location will provide a wide assortment of cannabis products from the Company’s branded portfolio that includes Cresco, One Plant, Supply (High Supply), Good News, Remedi and Sunnyside. The store also has a curated selection of accessories.

Patients can place orders today both in store and online through the retailer’s Sunnyside.shop website. Store hours are Monday through Saturday, 9 AM to 8 PM, and Sunday, 9 AM to 6 PM.

For more information, visit www.Sunnyside.shop.

About Cresco Labs

Cresco Labs is one of the largest vertically integrated multistate cannabis operators in the United States, with a mission to normalize and professionalize the cannabis industry. Employing a consumer-packaged goods (“CPG”) approach, Cresco Labs is the largest wholesaler of branded cannabis products in the U.S. Its brands are designed to meet the needs of all consumer segments and comprised of some of the most recognized and trusted national brands including Cresco, High Supply, Mindy's Edibles, Good News, Remedi, Wonder Wellness Co. and FloraCal Farms. Sunnyside, Cresco Labs’ national dispensary brand, is a wellness-focused retailer created to build trust, education and convenience for both existing and new cannabis consumers. Recognizing that the cannabis industry is poised to become one of the leading job creators in the country, Cresco Labs operates the industry’s largest Social Equity and Educational Development initiative, SEED, which was established to ensure that all members of society have the skills, knowledge and opportunity to work and own businesses in the cannabis industry. Learn more about Cresco Labs at www.crescolabs.com

Facebook: Cresco Labs
Twitter: Cresco Labs
LinkedIn: Cresco Labs

Media:

Jason Erkes, Cresco Labs

Chief Communications Officer

press@crescolabs.com

Investors:

Megan Kulick, Cresco Labs

Senior Vice President, Investor Relations

investors@crescolabs.com

For general Cresco Labs inquiries:

312-929-0993

info@crescolabs.com

Source: Cresco Labs

CRESCO LABS INC

OTC:CRLBF

CRLBF Rankings

CRLBF Latest News

CRLBF Stock Data

374.59M
271.34M
0.66%
5.5%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Chicago